Aker BioMarine ASA (OSL:AKBM)
Norway flag Norway · Delayed Price · Currency is NOK
78.00
-0.90 (-1.14%)
Aug 5, 2025, 3:41 PM CET

Verve Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Cash & Equivalents
19.51527.522.311.110.68
Upgrade
Cash & Short-Term Investments
19.51527.522.311.110.68
Upgrade
Cash Growth
19.63%-45.45%23.32%100.90%3.95%-21.54%
Upgrade
Accounts Receivable
51.447.357.659.950.353.72
Upgrade
Other Receivables
-1.88.35.210.110.39
Upgrade
Receivables
53.15066.265.160.464.11
Upgrade
Inventory
101.896.3183.7196.6138.2114.56
Upgrade
Prepaid Expenses
-5.15.63.717.333.78
Upgrade
Other Current Assets
20.135.37.11112.5-0
Upgrade
Total Current Assets
194.5201.7290.1298.7239.5223.12
Upgrade
Property, Plant & Equipment
56.351.6350.6343.1339.2279.7
Upgrade
Long-Term Investments
0.40.40.110.20.10.13
Upgrade
Goodwill
62.662.694.794.694.694.61
Upgrade
Other Intangible Assets
41.946.256.564.17485.87
Upgrade
Long-Term Deferred Tax Assets
2.25.725---
Upgrade
Long-Term Deferred Charges
17.815.87.49.210.19.24
Upgrade
Other Long-Term Assets
7.30.1---7.76
Upgrade
Total Assets
387387.4827.1822.4757.5700.43
Upgrade
Accounts Payable
46.116.330.13925.320.25
Upgrade
Accrued Expenses
-2331.414.917.615.22
Upgrade
Short-Term Debt
24.75.814.733.416.912.67
Upgrade
Current Portion of Long-Term Debt
--29.49.49.412.01
Upgrade
Current Portion of Leases
-1.44.94.84.47.54
Upgrade
Other Current Liabilities
3.36.72.43.23.73.24
Upgrade
Total Current Liabilities
74.153.2112.9104.777.370.94
Upgrade
Long-Term Debt
158.4138.7339.2327.8286.6204.34
Upgrade
Long-Term Leases
-1.64.85.87.56.23
Upgrade
Long-Term Deferred Tax Liabilities
4.98.33.75.44.94.82
Upgrade
Other Long-Term Liabilities
-11.7--0.110.640.74
Upgrade
Total Liabilities
237.4213.5460.6443.7387.1327.26
Upgrade
Common Stock
75.975.975.975.975.975.85
Upgrade
Additional Paid-In Capital
530.4530.3530.1530529.9529.9
Upgrade
Retained Earnings
-420.2-396.3-203.3-194.4-204.4-196.38
Upgrade
Comprehensive Income & Other
-36.5-36-36.2-32.8-31-36.2
Upgrade
Shareholders' Equity
149.6173.9366.5378.7370.4373.17
Upgrade
Total Liabilities & Equity
387387.4827.1822.4757.5700.43
Upgrade
Total Debt
183.1147.5393381.2324.8242.8
Upgrade
Net Cash (Debt)
-163.6-132.5-365.5-358.9-313.7-232.12
Upgrade
Net Cash Per Share
-1.88-1.51-4.17-4.10-3.58-2.97
Upgrade
Filing Date Shares Outstanding
86.9387.6987.6787.6487.5987.59
Upgrade
Total Common Shares Outstanding
86.9387.6987.6787.6487.5987.59
Upgrade
Working Capital
120.4148.5177.2194162.2152.18
Upgrade
Book Value Per Share
1.721.984.184.324.234.26
Upgrade
Tangible Book Value
45.165.1215.3220201.8192.69
Upgrade
Tangible Book Value Per Share
0.520.742.462.512.302.20
Upgrade
Buildings
23.623.620.619.618.818.62
Upgrade
Machinery
73.862.3469.8432.7448.6363.94
Upgrade
Construction In Progress
3.68.846.546.525.712.48
Upgrade
Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.